LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653.
   PubMed Web of Science ®Google Scholar
• Viola D, Valerio L, Molinaro E, et al. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat Cancer. 2016;23(4):R185–205.
   PubMed Web of Science ®Google Scholar
• Schneider DF, Chen H. New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin. 2013;63(6):374–394.
   PubMed Web of Science ®Google Scholar
• Gentile D, Orlandi P, Banchi M, et al. Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer. Med Oncol. 2020;37(3):19.
   PubMed Web of Science ®Google Scholar
• Lowe NM, Loughran S, Slevin NJ, et al. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival–a single centre experience and review of the literature. Sci World J. 2014;2014:674583.
   Web of Science ®Google Scholar
• Fallahi P, Ruffilli I, Elia G, et al. Novel treatment options for anaplastic thyroid cancer. Expert Rev Endocrino. 2017;12(4):279–288.
   PubMed Web of Science ®Google Scholar
• Al-Jundi M, Thakur S, Gubbi S, et al. Novel targeted therapies for metastatic thyroid cancer-A comprehensive review. Cancers (Basel). 2020;12(8).
   PubMed Web of Science ®Google Scholar
• Mi C, Zhang CC, Zhang Q, et al. Increased expression of lncRNA HULC in human epithelial ovarian cancer and its biological functions. Eur J Gynaecol Oncol. 2018;39(6):992–996.
   Web of Science ®Google Scholar
• Liu X, Fu Q, Li S, et al. LncRNA FOXD2-AS1 functions as a competing endogenous RNA to regulate TERT expression by sponging miR-7-5p in thyroid cancer. Front Endocrinol (Lausanne). 2019;10:207.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang K, Wang T, et al. Long non-coding RNA AFAP1-antisense RNA 1 promotes the proliferation, migration and invasion of gastric cancer cells and is associated with poor patient survival. Oncol Lett. 2018;15(6):8620–8626.
   PubMed Web of Science ®Google Scholar
• Bo H, Gong ZJ, Zhang WL, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. 2015;6(24):20404–20418.
   PubMedGoogle Scholar
• Huang N, Guo W, Ren K, et al. LncRNA AFAP1-AS1 supresses miR-139-5p and promotes cell proliferation and chemotherapy resistance of non-small cell lung cancer by competitively upregulating RRM2. Front Oncol. 2019;9. DOI:10.3389/fonc.2019.01103
   Web of Science ®Google Scholar
• Wang YM, Mo YZ, Yang X, et al. Long non-coding RNA AFAP1-AS1 is a novel biomarker in various cancers: a systematic review and meta-analysis based on the literature and GEO datasets. Oncotarget. 2017;8(60):102346–102360.
   PubMedGoogle Scholar
• Tan K, Ge Y, Tian J, et al. miRNA-9 inhibits apoptosis and promotes proliferation in angiotensin II-induced human umbilical vein endothelial cells by targeting MDGA2. Rev Cardiovasc Med. 2019;20(2):101–108.
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu Q, Zhang M, et al. MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2. J Integr Neurosci. 2019;18(1):57–64.
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen G, He J, et al. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer. Bioengineered. 2021;12(1):325–340.
   PubMed Web of Science ®Google Scholar
• Li YP, Du XR, Zhang R, et al. Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-beta1 axis. Bioengineered. 2021;12(1):763–778.
   PubMed Web of Science ®Google Scholar
• Li N, Cui T, Guo WL, et al. MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1. Oncol Targets Ther. 2019;12::3181–3196.
   Web of Science ®Google Scholar
• Ma HW, Xi DY, Ma JZ, et al. Long noncoding RNA AFAP1-AS1 promotes cell proliferation and metastasis via the miR-155-5p/FGF7 axis and predicts poor prognosis in gastric cancer. Dis Markers. 2020;2020:8140989.
   PubMed Web of Science ®Google Scholar
• Dittmer J. The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol. 2015;35::20–38.
   PubMed Web of Science ®Google Scholar
• Zhai W, Ma JJ, Zhu RJ, et al. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis. Br J Cancer. 2018;119(5):591–604.
   PubMed Web of Science ®Google Scholar
• Peyret V, Nazar M, Martin M, et al. Functional toll-like receptor 4 overexpression in papillary thyroid cancer by MAPK/ERK-induced ETS1 transcriptional activity. Mol Cancer Res. 2018;16(5):833–845.
   PubMed Web of Science ®Google Scholar
• Choi C, Tran NTT, Ngu TV, et al. Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways. Oncogenesis. 2018;7. DOI:10.1038/s41389-018-0094-y.
   Web of Science ®Google Scholar
• Boussemart L, Malka-Mahieu H, Girault I, et al. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature. 2014;513(7516):105-+.
   PubMed Web of Science ®Google Scholar
• Ji DL, Zhong XY, Jiang XM, et al. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol Res Pract. 2018;214(10):1524–1531.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou L, Lu J, et al. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Cancer Cell Int. 2020;20:457.
   PubMed Web of Science ®Google Scholar
• Rezaei M, Khamaneh AM, Zarghami N, et al. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules. BMC Cancer. 2019;19(1):690.
   PubMed Web of Science ®Google Scholar
• Wylie D, Beaudenon-Huibregtse S, Haynes BC, et al. Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations. J Pathol Clin Res. 2016;2(2):93–103.
   PubMedGoogle Scholar
• Kabbout M, Dakhlallah D, Sharma S, et al. MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation. PloS One. 2014;9(6):e100693.
   PubMed Web of Science ®Google Scholar
• Cao B, Tan S, Tang H, et al. miR‑512‑5p suppresses proliferation, migration and invasion, and induces apoptosis in non‑small cell lung cancer cells by targeting ETS1. Mol Med Rep. 2019. DOI:10.3892/mmr.2019.10022
   Google Scholar
• Wei JW, Huang K, Yang C, et al. Non-coding RNAs as regulators in epigenetics. Oncol Rep. 2017;37(1):3–9.
   PubMed Web of Science ®Google Scholar
• Long YC, Wang XY, Youmans DT, et al. How do lncRNAs regulate transcription? Sci Adv. 2017;3(9). DOI:10.1126/sciadv.aao2110
   Web of Science ®Google Scholar
• Dykes IM, Emanueli C. Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genom Proteom Bioinf. 2017;15(3):177–186.
   PubMed Web of Science ®Google Scholar
• Wilusz JE. Long noncoding RNAs: re-writing dogmas of RNA processing and stability. Bba-Gene Regul Mech. 2016;1859(1):128–138.
   Google Scholar
• Zhong YW, Wang YD, Dang HM, et al. LncRNA AFAP1-AS1 contributes to the progression of endometrial carcinoma by regulating miR-545-3p/VEGFA pathway. Mol Cell Probe. 2020; 53.
   Web of Science ®Google Scholar